117 related articles for article (PubMed ID: 26858930)
21. Release from Th1-type immune tolerance in spleen and enhanced production of IL-5 in Peyer's patch by cholera toxin B induce the glomerular deposition of IgA.
Yamanaka T; Tamauchi H; Suzuki Y; Suzuki H; Horikoshi S; Terashima M; Iwabuchi K; Habu S; Okumura K; Tomino Y
Immunobiology; 2016 Apr; 221(4):577-85. PubMed ID: 26719095
[TBL] [Abstract][Full Text] [Related]
22. Effect of dietary administration of the trichothecene vomitoxin (deoxynivalenol) on IgA and IgG secretion by Peyer's patch and splenic lymphocytes.
Pestka JJ; Dong W; Warner RL; Rasooly L; Bondy GS
Food Chem Toxicol; 1990 Oct; 28(10):693-9. PubMed ID: 2276698
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of immunoglobulin A production in Peyer's patches by oral administration of a traditional Chinese medicine, xiao-chai-hu-tang (Shosaiko-to).
Tauchi Y; Yamada A; Kawakita T; Saito Y; Suzuki A; Yoshikai Y; Nomoto K
Immunopharmacol Immunotoxicol; 1993; 15(2-3):251-72. PubMed ID: 8349952
[TBL] [Abstract][Full Text] [Related]
24. IgA responses in xid mice: oral antigen primes Peyer's patch cells for in vitro immune responses and secretory antibody production.
Kiyono H; Mosteller LM; Eldridge JH; Michalek SM; McGhee JR
J Immunol; 1983 Dec; 131(6):2616-22. PubMed ID: 6227659
[TBL] [Abstract][Full Text] [Related]
25. Aging-associated intrinsic defects in IgA production by murine Peyer's patch B cells stimulated by autoreactive Peyer's patch T cell hybridoma-derived B cell stimulatory factors (BSF).
Kawanishi H; Senda S; Ajitsu S
Mech Ageing Dev; 1989 Jul; 49(1):61-78. PubMed ID: 2787459
[TBL] [Abstract][Full Text] [Related]
26. Antigen-specific secretory IgA antibodies in the gut are decreased in a mouse model of food allergy.
Frossard CP; Hauser C; Eigenmann PA
J Allergy Clin Immunol; 2004 Aug; 114(2):377-82. PubMed ID: 15316519
[TBL] [Abstract][Full Text] [Related]
27. Effect of the
Peng YW; Jin HX
J Microbiol Biotechnol; 2018 Dec; 28(12):2009-2018. PubMed ID: 30304917
[No Abstract] [Full Text] [Related]
28. Biofilm formation by exopolysaccharide mutants of Leuconostoc mesenteroides strain NRRL B-1355.
Leathers TD; Côté GL
Appl Microbiol Biotechnol; 2008 Apr; 78(6):1025-31. PubMed ID: 18301888
[TBL] [Abstract][Full Text] [Related]
29. Effects of the oral administration of the exopolysaccharide produced by Lactobacillus kefiranofaciens on the gut mucosal immunity.
Vinderola G; Perdigón G; Duarte J; Farnworth E; Matar C
Cytokine; 2006 Dec; 36(5-6):254-60. PubMed ID: 17363262
[TBL] [Abstract][Full Text] [Related]
30. A proposal of Leuconostoc mesenteroides subsp. jonggajibkimchii subsp. nov. and reclassification of Leuconostoc mesenteroides subsp. suionicum (Gu et al., 2012) as Leuconostoc suionicum sp. nov. based on complete genome sequences.
Jeon HH; Kim KH; Chun BH; Ryu BH; Han NS; Jeon CO
Int J Syst Evol Microbiol; 2017 Jul; 67(7):2225-2230. PubMed ID: 28671527
[TBL] [Abstract][Full Text] [Related]
31. Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen.
Stanisz AM; Befus D; Bienenstock J
J Immunol; 1986 Jan; 136(1):152-6. PubMed ID: 2415614
[TBL] [Abstract][Full Text] [Related]
32. Dietary fructooligosaccharides induce immunoregulation of intestinal IgA secretion by murine Peyer's patch cells.
Hosono A; Ozawa A; Kato R; Ohnishi Y; Nakanishi Y; Kimura T; Nakamura R
Biosci Biotechnol Biochem; 2003 Apr; 67(4):758-64. PubMed ID: 12784615
[TBL] [Abstract][Full Text] [Related]
33. Oral vaccine models: multiple delivery systems employing tetanus toxoid.
Jackson RJ; Staats HF; Xu-Amano J; Takahashi I; Kiyono H; Hudson ME; Gilley RM; Chatfield SN; McGhee JR
Ann N Y Acad Sci; 1994 Aug; 730():217-34. PubMed ID: 8080173
[TBL] [Abstract][Full Text] [Related]
34. The role of CD4+ and CD8+ T cells on antibody production by murine Peyer's patch cells following mucosal presentation of Actinomyces viscosus.
Sosroseno W; Bird PS; Gemmell E; Seymour GJ
Oral Microbiol Immunol; 2006 Dec; 21(6):411-4. PubMed ID: 17064401
[TBL] [Abstract][Full Text] [Related]
35.
Chen YS; Wang LT; Wu YC; Mori K; Tamura T; Chang CH; Chang YC; Wu HC; Yi HH; Wang PY
Int J Syst Evol Microbiol; 2020 Mar; 70(3):1585-1590. PubMed ID: 32228772
[TBL] [Abstract][Full Text] [Related]
36. Effect of oral vs. parenteral cyclophosphamide on in vitro IgA and IgG production by murine Peyer's patches and cultured jejunal fragments.
Karacic JJ; Cowdery JS
Immunopharmacol Immunotoxicol; 1987; 9(4):441-65. PubMed ID: 3501798
[TBL] [Abstract][Full Text] [Related]
37. Regulation of mucosal IgA production in vitro by autoreactive immunoregulatory T cells from murine Peyer's patches.
Kawanishi H; Mirabella S
Cell Immunol; 1988 Jul; 114(2):324-35. PubMed ID: 2898979
[TBL] [Abstract][Full Text] [Related]
38. Enhanced mucosal and systemic immune responses to intestinal reovirus infection in beta2-microglobulin-deficient mice.
Major AS; Cuff CF
J Virol; 1997 Aug; 71(8):5782-9. PubMed ID: 9223466
[TBL] [Abstract][Full Text] [Related]
39. Paradoxical IgA immunity in CD4-deficient mice. Lack of cholera toxin-specific protective immunity despite normal gut mucosal IgA differentiation.
Hörnquist CE; Ekman L; Grdic KD; Schön K; Lycke NY
J Immunol; 1995 Sep; 155(6):2877-87. PubMed ID: 7673704
[TBL] [Abstract][Full Text] [Related]
40. Isotype-specific immunoregulation. Evidence for a distinct subset of T contrasuppressor cells for IgA responses in murine Peyer's patches.
Suzuki I; Kitamura K; Kiyono H; Kurita T; Green DR; McGhee JR
J Exp Med; 1986 Aug; 164(2):501-16. PubMed ID: 2941516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
